M. A. Greenwald, M. J. Kuehnert, and J. A. Fishman, Infectious disease transmission during organ and tissue transplantation, Emerg Infect Dis, vol.18, p.1, 2012.

H. H. Hirsch, N. Babel, and P. Comoli, European perspective on human polyomavirus infection, replication and disease in solid organ transplantation, Clin Microbiol Infect, vol.20, issue.7, pp.74-88, 2014.

L. Garaicoechea, A. Aguilar, and G. I. Parra, Llama nanoantibodies with therapeutic potential against human norovirus diarrhea, PLoS One, vol.10, p.133665, 2015.

R. R. Razonable, A. Asberg, and H. Rollag, Virologic suppression measured by a cytomegalovirus (CMV) DNA test calibrated to the World Health Organization international standard is predictive of CMV disease resolution in transplant recipients, Clin Infect Dis, vol.56, pp.1546-1553, 2013.

R. R. Razonable and R. T. Hayden, Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation, Clin Microbiol Rev, vol.26, pp.703-727, 2013.

J. Dechanet, P. Merville, and A. Lim, Implication of gammadelta T cells in the human immune response to cytomegalovirus, J Clin Invest, vol.103, pp.1437-1449, 1999.

L. Couzi, Y. Levaillant, and A. Jamai, Cytomegalovirus-induced gammadelta T cells associate with reduced cancer risk after kidney transplantation, J Am Soc Nephrol, vol.21, pp.181-188, 2010.

T. Bachelet, L. Couzi, and V. Pitard, Cytomegalovirus-responsive gammadelta T cells: novel effector cells in antibody-mediated kidney allograft microcirculation lesions, J Am Soc Nephrol, vol.25, pp.2471-2482, 2014.

F. Perosa, G. Luccarelli, and M. Prete, Beta 2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide, J Immunol, vol.171, pp.1918-1926, 2003.

G. Sarrabayrouse, C. Bossard, and J. M. Chauvin, CD4CD8alphaalpha lymphocytes, a novel human regulatory T cell subset induced by colonic bacteria and deficient in patients with inflammatory bowel disease, PLoS Biol, vol.12, p.1001833, 2014.

S. Naik, N. Bouladoux, and J. L. Linehan, Commensal-dendritic-cell interaction specifies a unique protective skin immune signature, Nature, vol.520, pp.104-108, 2015.

E. S. Mocarski, Immune escape and exploitation strategies of cytomegaloviruses: impact on and imitation of the major histocompatibility system, Cell Microbiol, vol.6, pp.707-717, 2004.

P. F. Cespedes, S. M. Bueno, and B. A. Ramirez, Surface expression of the hRSV nucleoprotein impairs immunological synapse formation with T cells, Proc Natl Acad Sci, vol.111, pp.3214-3223, 2014.

S. M. Bueno, P. A. Gonzalez, and K. M. Cautivo, Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG, Proc Natl Acad Sci, vol.105, pp.20822-20827, 2008.

J. A. Espinoza, K. Bohmwald, and P. F. Cespedes, Impaired learning resulting from respiratory syncytial virus infection, Proc Natl Acad Sci U S A, vol.110, pp.9112-9117, 2013.

L. K. Selin, S. M. Varga, and I. C. Wong, Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations, J Exp Med, vol.188, pp.1705-1715, 1998.

A. L. Amir, D. 'orsogna, L. J. Roelen, and D. L. , Allo-HLA reactivity of virusspecific memory T cells is common, Blood, vol.115, pp.3146-3157, 2010.

J. R. Teijaro, C. Ng, and A. M. Lee, Persistent LCMV infection is controlled by blockade of type I interferon signaling, Science, vol.340, pp.207-211, 2013.

E. B. Wilson, D. H. Yamada, and H. Elsaesser, Blockade of chronic type I interferon signaling to control persistent LCMV infection, Science, vol.340, pp.202-207, 2013.

F. Bohne, M. C. Londono, and C. Benitez, HCV-induced immune responses influence the development of operational tolerance after liver transplantation in humans, Sci Transl Med, vol.6, pp.242-281, 2014.

L. Gattinoni, E. Lugli, and Y. Ji, A human memory T cell subset with stem cell-like properties, Nat Med, vol.17, pp.1290-1297, 2011.

M. Schmueck-henneresse, R. Sharaf, and K. Vogt, Peripheral bloodderived virus-specific memory stem T cells mature to functional effector memory subsets with self-renewal potency, J Immunol, vol.194, pp.5559-5567, 2015.

A. Papadopoulou, U. Gerdemann, and U. L. Katari, Activity of broadspectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT, Sci Transl Med, vol.6, pp.242-283, 2014.

J. M. Pawlotsky, New hepatitis C therapies: the toolbox, strategies, and challenges, Gastroenterology, vol.146, pp.1176-1192, 2014.

J. D. Sander and J. K. Joung, CRISPR-Cas systems for editing, regulating and targeting genomes, Nat Biotechnol, vol.32, pp.347-355, 2014.

W. Hu, R. Kaminski, and F. Yang, RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection, Proc Natl Acad Sci, vol.111, pp.11461-11466, 2014.

S. R. Lin, H. C. Yang, and Y. T. Kuo, The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo, Mol Ther Nucleic Acids, vol.3, p.186, 2014.

T. A. Russell, T. Stefanovic, and D. C. Tscharke, Engineering herpes simplex viruses by infection-transfection methods including recombination site targeting by CRISPR/Cas9 nucleases, J Virol Methods, vol.213, pp.18-25, 2015.

J. Wang and S. R. Quake, RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection, Proc Natl Acad Sci U S A, vol.111, pp.13157-13162, 2014.

S. Zhen, L. Hua, and Y. Takahashi, In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by CRISPR/ Cas9, Biochem Biophys Res Commun, vol.450, pp.1422-1426, 2014.

D. Vlaminck, I. Khush, K. K. Strehl, and C. , Temporal response of the human virome to immunosuppression and antiviral therapy, Cell, vol.155, pp.1178-1187, 2013.

A. Liacini, M. E. Seamone, and D. A. Muruve, Anti-BK virus mechanisms of sirolimus and leflunomide alone and in combination: toward a new therapy for BK virus infection, Transplantation, vol.90, pp.1450-1457, 2010.

F. A. Tohme, R. S. Kalil, and C. P. Thomas, Conversion to a sirolimus-based regimen is associated with lower incidence of BK viremia in low-risk kidney transplant recipients, Transpl Infect Dis, vol.17, pp.66-72, 2015.

D. C. Brennan, C. Legendre, and D. Patel, Cytomegalovirus incidence between everolimus versus mycophenolate in de novo renal transplants: pooled analysis of three clinical trials, Am J Transplant, vol.11, pp.2453-2462, 2011.

S. H. Havenith, S. L. Yong, and K. A. Van-donselaar-van-der-pant, Everolimustreated renal transplant recipients have a more robust CMV-specific CD8+

, T-cell response compared with cyclosporine-or mycophenolate-treated patients, Transplantation, vol.95, pp.184-191, 2013.

R. T. Neff, R. M. Jindal, and D. Y. Yoo, Analysis of USRDS: incidence and risk factors for Pneumocystis jiroveci pneumonia, Transplantation, vol.88, pp.135-141, 2009.

S. C. Chen, R. E. Lewis, and D. P. Kontoyiannis, Direct effects of non-antifungal agents used in cancer chemotherapy and organ transplantation on the development and virulence of Candida and Aspergillus species, Virulence, vol.2, pp.280-295, 2011.

A. Safdar, Immunotherapy for invasive mold disease in severely immunosuppressed patients, Clin Infect Dis, vol.57, pp.94-100, 2013.